Andrew Fritts

Andrew Fritts possesses extensive experience in the life sciences and biotechnology sectors, highlighted by a tenure at Thermo Fisher Scientific from August 2013 to May 2024, where roles included Sr. Life Science Specialist and Technical Sales Specialist. Expertise encompasses cell culture, microbiology, and molecular biology, with a focus on promoting EVOS Cell Imaging Systems. Prior positions include Account Director for Science Exchange and Strategic Account Manager at QIAGEN, specializing in molecular diagnostics. Earlier experience includes roles at Roche Diagnostics as a Reagent Account Manager and Lead Generation Specialist. Andrew Fritts holds a B.S. in Biology from Ball State University and completed business coursework at Indiana University Indianapolis.